Our new product Tragliptin (linagliptin, tablets 5 mg) is among the newest oral antihyperglycemic agents.

Tragliptin inhibits DPP4 enzyme. It is highly effective and convenient for all patients (elderly, hepatic or renal impairment, …) without any need for dose adjustment.